Clinical Impact of Fluoroquinolone-Resistant Escherichia coli in the Fecal Flora of Hematological Patients with Neutropenia and Levofloxacin Prophylaxis
Explore this paper's citation graph
Summary
Levofloxacin prophylaxis for neutropenia did not result in a significant acquisition of quinolone-resistant E. coli, and FN-related bacteremia developed in 2 patients, accompanied by a good prognosis.
- Type
- article
- Published
- 2014-01-22
- Cited by
- 24
- References
- 28
- Access
- Open access
- OpenAlex
- https://openalex.org/W1988742113
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:16880776
Keywords
Levofloxacin, Ciprofloxacin, Neutropenia, Quinolone, Medicine
References
- Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies.
- National Committee for Clinical Laboratory Standards.
- Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients
- The CTX-M beta-lactamase pandemic.
- Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin‐resistant Escherichia coli
- The role of prophylactic antimicrobials during autologous stem cell transplantation: a single-center experience
- Effects on spectrum and susceptibility patterns of isolates causing bloodstream infection by restriction of fluoroquinolone prophylaxis in a hematology–oncology unit
- Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens.
- The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit
- Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.
- Genetic evolution and clinical impact in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
- Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.
- Treatment of febrile neutropenia: what is new?
- Prevention of febrile neutropenia: use of prophylactic antibiotics
- Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients
- Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
- Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis
- Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
- Community spread of extended-spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis: a long-term study in Japan.
- Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis.
Cited by
- Prophylactic efficacy of cephamycin plus fluoroquinolones in high risk patients on inhibiting infectious complications after transrectal prostate biopsy
- Escherichia Coli: an Important Pathogen in Patients with Hematologic Malignancies
- Infection Prevention in Transplantation
- Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study
- Outpatient management without initial assessment for febrile patients undergoing adjuvant chemotherapy for breast cancer.
- Colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis.
- Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis
- Colonization and infection with extended-spectrum beta-lactamase producing Enterobacteriaceae in patients with malignancy
- E. coli O124 K72 alters the intestinal barrier and the tight junctions proteins of guinea pig intestine.
- Clinical impact of levofloxacin prophylaxis in neutropenic patients with hematological malignancies Before and after study in a fourth-level Colombian hospital
- Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines.
- Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients
- Fecal Carriage of Extended-Spectrum β-Lactamase and Carbapenemase-Producing Enterobacterales Strains in Patients with Colorectal Cancer in the Oncology Unit of Amizour Hospital, Algeria: A Prospective Cohort Study
- Association between the rate of fluoroquinolones-resistant gram-negative bacteria and antibiotic consumption from China based on 145 tertiary hospitals data in 2014
- Resistance to Antibiotics of Uropathogen Bacteria Isolated From Urine and Blood in Pediatric Cancer Patients
- Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)
- Detection of qnr genes and gyrA mutation to quinolone phenotypic resistance of UTI pathogens in Bangladesh and the implications
- Prophylactic antibiotics on patients with cirrhosis and upper gastrointestinal bleeding: A meta-analysis
- Fluoroquinolone resistance among fecal extended spectrum βeta lactamases positive Enterobacterales isolates from children in Dar es Salaam, Tanzania
- Fluoroquinolone prophylaxis in patients with neutropenia at high risk of serious infections: Exploring pros and cons
Related papers
- Efficacy of levofloxacin eye drops in the treatment of bacterial conjunctivitis and keratitis
- A Double‐Blind, Randomized Trial of the Efficacy and Safety of Short‐Course, Once‐Daily Levofloxacin Versus Ofloxacin Twice Daily in Uncomplicated Urinary Tract Infections
- Ocular penetration of levofloxacin, ofloxacin and ciprofloxacin in eyes with functioning filtering blebs: investigator masked, randomised clinical trial
- Corneal penetration of fluoroquinolones: Aqueous humor concentrations after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedrops
- Comparative Ocular Bioavailability and Efficacy of Topical Levofloxacin and Ofloxacin in Rabbits
- Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin.
- A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
- Pharmacodynamics of levofloxacin and ofloxacin against Streptococcus pneumoniae.
- Phase I Study of Levofloxacin, (S)-(-)-Ofloxacin.